Peptide therapy TikTok claims: what the research actually supports

What's this video probably claiming?

Based on the peptides category tag and the general TikTok peptide creator ecosystem, this video is likely making broad claims about the benefits of peptides like BPC-157, TB-500, CJC-1295, ipamorelin, or GHK-Cu for recovery, anti-aging, fat loss, or muscle gain. Creators in this space frequently position these compounds as safe, effective, and accessible alternatives to pharmaceutical interventions. The framing usually goes something like: peptides are natural signaling molecules your body already makes, so supplementing with them is inherently low-risk. That framing is worth interrogating closely, because it sidesteps the question of whether injecting a synthetic version of a peptide at pharmacological doses produces the same effect, or a very different one.

What does the science actually show?

The honest answer is: not much in humans, yet. BPC-157, arguably the most-hyped peptide in this space, has demonstrated genuine tissue-healing and anti-inflammatory effects in rodent models. Chang et al. (1997, Journal of Physiology-Paris) showed accelerated tendon healing in rats at 10 mcg/kg doses. Sikiric et al. have published dozens of animal studies over three decades showing gastric cytoprotection and nerve regeneration. But as of 2024, there are zero published randomized controlled trials in humans for BPC-157. TB-500, a synthetic fragment of thymosin beta-4, similarly has animal data suggesting angiogenesis and cardiac repair, but human trial data is essentially nonexistent. CJC-1295 and ipamorelin have slightly more human data: a 2006 study by Jetté et al. in Growth Hormone and IGF Research showed CJC-1295 increased IGF-1 levels by 200-300% in healthy adults, which sounds impressive until you consider that sustained IGF-1 elevation carries its own risk profile.

Where does the social media noise diverge from clinical reality?

The gap is substantial. TikTok peptide content routinely conflates animal study results with human outcomes, skips over the fact that most of these compounds are not FDA-approved for any indication, and downplays the regulatory reality that many are sourced from unregulated research chemical suppliers with inconsistent purity. A 2020 analysis published in JAMA Internal Medicine found that a significant proportion of compounded peptide products tested contained incorrect doses or contaminants. The "natural signaling molecule" argument also does a lot of heavy lifting it cannot support. Insulin is a natural signaling molecule. That does not mean injecting arbitrary doses of it is safe. MK-677, frequently bundled into peptide stacks despite being an oral ghrelin mimetic and not technically a peptide, has shown appetite stimulation and GH pulse amplification in trials, but also fluid retention and insulin resistance in longer-term use. Frischknecht et al. (2003, Journal of Clinical Endocrinology and Metabolism) documented these side effects at 25 mg daily over 12 months.

What should you actually know?

Peptide therapy is a real and evolving area of medicine with legitimate clinical applications. GHK-Cu has credible data for skin wound healing and topical applications. Growth hormone secretagogues like ipamorelin have a rational pharmacological basis for use in GH-deficient adults under physician supervision. The problem is not the compounds themselves but the gap between where the science currently sits and how they are being marketed. Sourcing matters enormously: peptides obtained outside of licensed compounding pharmacies or physician-supervised programs carry real contamination and dosing risks. Anyone considering these compounds should be working with a licensed provider who can order baseline labs, monitor IGF-1, and assess individual risk factors. Self-administering injectable peptides based on TikTok content is not a reasonable risk-benefit calculation regardless of how confident the creator sounds.